Skip to content

Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis

Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001501-42-FI
Enrollment
Unknown
Registered
2008-03-18
Start date
2008-05-15
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painful bladder syndrome / interstitial cystitis (PBS/IC) MedDRA version: 1 Level: LLT Classification code 10005063 Term:

Interventions

Trade Name: Prograf Pharmaceutical Form: INN or Proposed INN: TACROLIMUS CAS Number: 104987113

Sponsors

Jukka Sairanen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026